Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status

BJU International

Volumn 86, Issue 1, 2000, Pages 32-38

  Blakeman, P J ^a   Hilton, P ^b   Bulmer, J N ^b  

^a CUMBERLAND INFIRMARY   (United Kingdom)

^b NONE

Author keywords

Lower urinary tract; Oestrogen; Progesterone; Receptors

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BIOPSY; BLADDER; EPITHELIUM; ESTROGEN THERAPY; FEMALE; HORMONE ACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; URETHRA; VAGINA;

BIOPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; URINARY INCONTINENCE; URINARY TRACT;

EID: 0033937251     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00724.x     Document Type: Article

References (40)

1. 1 McCallin PF, Taylor ES, Whitehead RW. A study of the changes in the cytology of the urinary sediment during the menstrual cycle and pregnancy. Am J Obstet Gynecol 1950; 60: 64-74
2. 2 Ulmsten U, Stormby N. Evaluation of the urethral mucosa before and after oestrogen treatment in postmenopausal women with a new sampling technique. Gynecol Obstet Invest 1987; 24: 208-11
3. 3 Bergman A, Karram MM, Bhatia NN. Changes in urethral cytology following estrogen administration. Gynecol Obstet Invest 1990; 29: 211-3
4. 4 Cutner A, Burton G, Cardozo LD, Wise BG, Abbott D, Studd J. Does progesterone cause an irritable bladder? Int Urogynecol J 1993; 4: 259-61
5. 5 Benness C, Abbott D, Cardozo L, Savvas M, Studd J. Lower urinary tract dysfunction in postmenopausal women - the role of estrogen deficiency. Neurourol Urodyn 1991; 10: 315-6
6. 6 Benness C, Gangar K, Cardozo L, Cutner A, Whitehead M. Do progestogens exacerbate urinary incontinence in women on HRT? Neurourol Urodyn 1991; 10: 316-7
7. 7 Burton G, Cardozo LD, Abdalla H, kirkland A, Studd JW. The hormonal effects on the lower urinary tract in 282 women with premature ovarian failure. Neurourol Urodyn 1991; 10: 318-9
8. 8 Foldspang A, Mommsen S. The menopause and urinary incontinence. Int Urogynecol J 1994; 5: 195-201
9. 9 Fantl JA, Wyman JR, Anderson RL, Matt DW, Bump RC. Postmenopausal urinary incontinence: comparison between non-estrogen-supplemented and estrogen-supplemented women. Obstet Gynecol 1988; 71: 823-8
10. 10 Versi E, Cardozo LD, Brincat M, Cooper D, Montgomery J. The long term effect of hormone implant therapy on the lower urinary tract. Int Urogynecol J 1990; 1: 87-90
11. 11 Hilton P, Stanton SL. The use of intravaginal oestrogen cream in genuine stress incontinence. Br J Obstet Gynaecol 1983; 90: 940-4
12. 12 Wilson PD, Faragher B, Butler B, Bu-Lock D, Robinson EL, Brown AD. Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. Br J Obstet Gynaecol 1987; 94: 568-74
13. 13 Privette M, Cade R, Peterson J, Mars D. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988; 50: 24-7
14. 14 Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New Eng J Med 1993; 329: 753-6
15. 15 Van Geelen JM, Doesburg WH, Thomas CMG, Martin CB. Urodynamic studies in the normal menstrual cycle: The relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol 1981; 141: 384-92
16. 16 Van Geelen JM, Lemmens WAJG, Eskes TKAB, Martin CB. The urethral pressure profile in pregnancy and after delivery in healthy nulliparous women. Am J Obstet Gynecol 1982; 144: 636-49
17. 17 Stanton SL, Kerr-Wilson R, Harris VG. The incidence of urological symptoms in normal pregnancy. Br J Obstet Gynaecol 1980; 87: 897-900
18. 18 Fantl JA, Cardozo L, McClish DK. The hormones and urogenital therapy committee. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 1994; 83: 12-8
19. 19 Fantl JA, Bump R, McClish D, Wyman J. Efficacy of estrogen supplementation in the treatment of urinary incontinence. Obstet Gynecol 1996; 88: 745-9
20. 20 Jackson S, Shepherd A, Brookes S, Abrams P. The effect of oestrogen supplementation on postmenopausal urinary stress incontinence: a double blind placebo controlled trial. Br J Obstet Gynaecol 1999; 106: 711-8
21. 21 Saez S, Martin PM. Evidence of estrogen receptors in the trigone area of the human urinary bladder. J Steroid Biochem 1981; 15: 317-20
22. 22 Iosif CS, Batra S, Anders EK, Astedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981; 141: 817-20
23. 23 Punnonen R, Lukola A, Puntala P. Lack of estrogen and progestin receptors in the urinary bladder of women. Harm Metabol Res 1983; 15: 464-5
24. 24 Wilson PD, Barker G, Barnard RJ, Siddle NC. Steroid hormone receptors in the female lower urinary tract. Urol Int 1984; 39: 5-8
25. 25 Van Haaften M, Poortman J, Donker GH, Wiegerinck MAHM, Haspels AA, Thijssen JHH. Effects of oestriol: Preliminary results on receptor kinetics in target tissues of postmenopausal women. J Steroid Biochem 1984; 20: 1015-9
26. 26 Stephenson TJ, Henry L, Harris SC, Giri DD, Fox M, Underwood JCE. Pseudomembranous trigonitis of the bladder: hormonal aetiology. J Clin Pathol 1989; 42: 922-6
27. 27 Bussolati G, Tizzani A, casetta G et al. Detection of estrogen receptors in the trigonum and urinary bladder with an immunohistochemical technique. Gynecol Endocrinol 1990; 4: 205-13
28. 28 Wolf H, Wandt H, Jonat W. Immunohistochemical evidence of estrogen and progesterone receptors in the female lower urinary tract and comparison with vagina. Gynecol Obstet Invest 1991; 32: 227-31
29. 29 Pacchioni D, Revelli A, Casetta G et al. Immunohistochemical detection of estrogen and progesterone receptors in the normal urinary bladder and in pseudomembranous trigonitis. J Endocrinol Invest 1992; 15: 719-25
30. 30 Strittmatter H-J, Wischnik A, Pollow K, Weigel M, Voges G, Melchert F. Steroid hormone receptors in the female urogenital tract. Int Urogynecol J 1994; 5: 146-53
31. 31 Bodker A, Balslev E, Juul BR et al. Estrogen receptors in the human male bladder, prostatic urethra and prostate. Scand J Urol Nephrol 1995; 29: 161-5
32. 32 Pang X, Cotreau-Bibbo MM, Sant GR, Theoharides TC. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br J Urol 1995; 75: 154-61
33. 33 Letourneau R, Pang X, Sant GR, Theoharides TC. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 1996; 77: 41-54
34. 34 Sjoberg I, Rylander E, von Schoultz B. Menstrual variation of estrogen receptor content in vaginal tissue. Gynecol Obstet Invest 1989; 27: 48-51
35. 35 Jones RK, Bulmer JN, Searle RF. Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum Reprod 1995; 10: 3272-9
36. 36 Aasmundstad TA, Haugen OA, Johannesen E, Hoe Al Kvinnsland S. Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol 1992; 45: 125-9
37. 37 Hilton P, Tweddell AL, Mayne C. Oral and intravaginal estrogens alone and in combination with α-adrenergic stimulation in genuine stress incontinence. Int Urogynecol J 1990; 1: 80-6
38. 38 Walter S, Kjaergaard B, Lose G et al. Stress urinary incontinence in postmenopausal women treated with oral estrogen and an α-adrenoceptor stimulating agent: a randomised double-blind placebo-controlled study. Int Urogynecol J 1990; 1: 74-9
39. 39 Jackson S, Avery N, Shepherd A, Abrams P, Bailey A. The effect of oestradiol on vaginal collagen in postmenopausal women with stress urinary incontinence. Neurourol Urodyn 1996; 15: 327-8
40. 40 Ferenczy A, Bertrand G, Gelfand MM. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979; 133: 859-97